iShares Genomics Immunology and Healthcare Index ETF CAD (XDNA:CA) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the iShares Genomics Immunology and Healthcare Index ETF CAD stock forecast from 0 analysts, the average analyst target price for iShares Genomics Immunology and Healthcare Index ETF CAD is not available over the next 12 months. iShares Genomics Immunology and Healthcare Index ETF CAD’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of iShares Genomics Immunology and Healthcare Index ETF CAD is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, iShares Genomics Immunology and Healthcare Index ETF CAD’s stock price was CAD 31.95. iShares Genomics Immunology and Healthcare Index ETF CAD’s stock price has changed by +3.36% over the past week, -2.56% over the past month and -2.05% over the last year.
No recent analyst target price found for iShares Genomics Immunology and Healthcare Index ETF CAD
No recent average analyst rating found for iShares Genomics Immunology and Healthcare Index ETF CAD
Company Overview iShares Genomics Immunology and Healthcare Index ETF CAD
Frequently Asked Questions About iShares Genomics Immunology and Healthcare Index ETF CAD (XDNA:CA) Stock
Stock Target Advisor's fundamental analysis for iShares Genomics Immunology and Healthcare Index ETF CAD's stock is Very Bearish.
XDNA:CA stock's dividend yield is 0.24%.
Our analysis grades XDNA:CA stock's dividend yield at F. This means that XDNA:CA stock's dividend yield is above 3% of the stocks in the Others sector in the TSX exchange.
Based on this XDNA:CA may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on XDNA:CA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on XDNA:CA's stock to indicate if its overvalued.
The last closing price of XDNA:CA's stock was CAD 31.95.
The most recent market capitalization for XDNA:CA is CAD 4.63M.
Unfortunately we do not have enough analyst data on XDNA:CA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains iShares Genomics Immunology and Healthcare Index ETF CAD's stock.
Sorry, we do not have any data on the number of employees for iShares Genomics Immunology and Healthcare Index ETF CAD.
Sorry we do not have any infomation available on iShares Genomics Immunology and Healthcare Index ETF CAD's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for XDNA:CA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
